Changes in Food Waste among a Sample of U.S. Consumers after Beginning Anti-Obesity Medication.

ABSTRACT:

Background/objectives

Glucagon-like peptide-1 agonists (GLP1As) are increasingly prescribed to treat obesity. While studies document how these medications impact dietary habits, their relationship to consumer food waste is unexplored. Approximately one-third of all food is wasted, which creates substantial economic and environmental damage. The purpose of this study is to assess how consumers alter food waste after beginning GLP1As and to identify factors associated with this relationship.

Methods

Retrospectively reported changes in the amount of food wasted since beginning a GLP1A are gathered from a sample of 505 U.S. consumers via a self-administered online survey. Regression analysis yields associations between changes in post-GLP1A-uptake food waste and the length and t

SUBMITTER: Mansouri J 

PROVIDER: S-EPMC11478882 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature